Analyst Ratings for Arcutis Biotherapeutics Inc. (ARQT)
ARQT Rating Summary
ARQT Price Target Summary
- Highest: $36.00 (Needham)
- Lowest: $29.00 (Guggenheim)
- Average: $33.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.71 (+28.6%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$33.71 (+28.6%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/25/2025 | Goldman Sachs » Updated 2/27/2026 |
Richard Law | New Coverage | Neutral (N/A) |
33.00 (29.00) |
14.91 (26.21) |
75.79% | Details |
| 7/3/2025 | Morgan Stanley » Updated 5/7/2026 |
Judah Frommer | New Coverage | Overweight (N/A) |
34.00 (35.00) |
13.76 (26.21) |
90.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
